French health authorities will keep on supporting the development of the retail generics for economic reasons.
However, the market leaders will be the best positioned to seize this opportunity.
This new publication analyses the current business environment and estimates the 2027 gross and net sales perspectives for this market segment.
For so doing, Smart Pharma consultants have capitalized on their long experience and strong expertise re. generics market.